ACSL3	Acyl-coenzyme A (CoA) synthetase long-chain family member 3;
AKT	Protein kinase B;
AMPK	5′ AMP-activated protein kinase;
6-AN	6-anicotinamide;
Anlo	Anlotinib;
APC	Adenomatous polyposis coli;
ASK1	Apoptosis signal-regulating kinase 1;
ATPP-DTPA	5-(4-amino-phenyl)-10,15,20-triphenylporphyrin-diethylene-triaminopentaacetic acid;
ATF4	Activating transcription factor 4;
BER	Base excision repair;
BMP	Bone morphogenetic protein;
BRAF	B-Raf proto-oncogene;
CAFs	Cancer-associated fibroblasts;
CAT	Catalase;
CDDP	Cisplatin;
CDK	Cyclin-dependent kinase;
CIN	Chromosomal instability;
CIOSS	CRC-integrated OS score;
CM-H2DCFDA	5-(and 6)-chloromethyl-2′,7′-dichlorohydrofluorescein diacetate;
COX-2	Cyclooxygenase-2;
CPT-11	Irinotecan;
CRC	Colorectal cancer;
CTLA-4	Cytotoxic T lymphocyte-associated protein 4;
CtBP1	C-terminal binding protein-1;
CXCL2	C-X-C motif chemokine ligand 2;
Cyt-c	Cytochrome-c;
DCF	2′,7′-dichlorofluorescein;
DHA	Dihydroartemisinin;
DHE	Dihydroethidium;
d-ROMs	Reactive oxygen metabolite derivatives;
Dvl	Dishevelled protein 1;
DTNB	5,5′-dithio-bis(2-nitrobenzoic acid);
EGFR	Epidermal growth factor receptor;
ELISA	Enzyme-linked immunosorbent assay;
EMT	Epithelial-to-mesenchymal transition;
ER	Endoplasmic reticulum;
ERK	Extracellular signal-regulated kinase;
FGFR	Fibroblast growth factor receptor;
FLIM	Fluorescence lifetime imaging microscopy;
5-FU	5-fluorouracil;
G6PD	Glucose-6-phosphatedehydrogenase;
GGT2	Gamma-glutamyltransferase 2;
GOT1	Glutamic-oxaloacetic transaminase 1;
GPXs	Glutathione peroxidases
GSH	Glutathione;
GSS	Glutathione synthase;
GSSG	Oxidized glutathione
GSTs	Glutathione S-transferases;
Gyp	Gypenosides;
H2DCF	2′,7′-dichlorodihydrofluorescein;
H2DCFDA	2′,7′-dichlorodihydrofluorescein diacetate;
H2O2	Hydrogen peroxide;
HER	Human epidermal growth factor receptor;
HIF-1α	Hypoxia-inducible factor 1α;
HPLC	High-pressure liquid chromatography;
HY-PDT	Photodynamic therapy mediated by hypericin;
IBD	Inflammatory bowel diseases;
ICAM-1	Intercellular adhesion molecule 1;
IFN	Interferon;
IFN-α	Interferon-alpha;
IKK	Inhibitor κB kinase;
ISC	Intestinal stem cell;
JAK	Janus kinase;
JNK	c-Jun N-terminal kinase;
Keap1	Kelch-like ECH-associated protein 1;
KRAS	KRAS proto-oncogene, GTPase;
LncRNAs	Long noncoding RNAs;
L-OHP	Oxaliplatin;
mAbs	Monoclonal antibodies;
MAPK	Mitogen-activated protein kinase;
MAP3K	Mitogen-activated protein kinase kinase kinase;
MDA	Malondialdehyde;
MDR	Multidrug resistance;
MEK	Mitogen-activated protein kinase kinase-MAPKK;
MET	Metformin;
MLK3, MAP3K11	Mixed lineage kinase 3;
MMR	Mismatch repair;
MPO	Myeloperoxidase;
MSI	Microsatellite instability;
MSI-H	Microsatellite instability-high;
mTOR	Mammalian target of rapamycin;
MUTYH	MutY homolog Escherichia coli, homolog of MYH, hMYH;
MVs	Membrane vesicles;
NaB	Sodium butyrate;
NAC	N-acety1 cysteine;
NADPH	Nicotinamide adenine dinucleotide phosphate;
NPs	Nanoparticles;
NER	Nucleotide excision repair;
NF-κB	Nuclear factor kappa B;
NIK	NF-κB inducing kinase;
NOTCH	Notch receptor;
NOX	NADPH oxidase;
NRAS	NRAS proto-oncogene, GTPase;
NRF2	Nuclear factor-erythroid 2 p45-related factor 2;
NRX	Nucleoredoxin;
NSAIDs	Nonsteroidal anti-inflammatory drug;
O2•−	Superoxide anion;
OGG1	8-oxoguanine DNA glycosylase 1;
•OH	Hydroxyl radical;
8-OHdG	8-hydroxy-2′-deoxyguanosine;
8-oxoG	8-oxoguanine;
8-oxodG	8-oxo-7, 8-dihydro-2′-deoxyguanosine;
oxLDL	Oxidized low-density lipoprotein;
OS	Oxidative stress
P3C-Asp	Dextran–aspirin nanomedicine;
PD-1	Programmed cell death 1;
PDGF-R	Platelet-derived growth factor receptors;
PDL1	Programmed death ligand 1;
PDT	Photodynamic therapy;
PFL	Positive feedback loop;
P-gp	P-glycoprotein;
PI3K	Phosphatidyl inositol 3-OH kinase;
PKB	Protein kinase B;
PL	Piperlongumine;
PMN	Polymorphonuclear;
PPP	Pentose phosphate pathway;
PRX	Peroxiredoxin;
PTEN	Phosphatase and tensin homolog;
PTKs	Protein tyrosine kinases;
PTP	Protein tyrosine phosphatase;
PUFAs	Polyunsaturated fatty acids;
PL	Piperlongumine;
qPCR	Quantitative real-time polymerase chain reaction;
RAC1	Rac family small GTPase 1;
ROS	Reactive oxygen species;
RTKs	Receptor tyrosine kinases;
SA	Salicylic acid;
SalB	Salvianolic acid B;
SCD1	Stearoyl-CoA desaturase-1;
SLC7A11	Solute carrier family 7 member 11;
SMAD4	SMAD family member 4/mothers against decapentaplegic homolog 4;
SOD	Superoxide dismutase;
STAT	Signal transducer of activators of transcription;
TALDO1	Transaldolase 1;
TAMs	Tumor-associated macrophages;
TANs	Tumor-associated neutrophils;
TBA	Modified 2-thiobarbituric acid;
TBARS	Thiobarbituric acid reactive;
TCA	Tricarboxylic acid cycle;
TCF-4	T-cell factor-4;
TCRs	T-cell receptors;
TIGAR	TP53-induced glycolysis regulatory phosphatase;
TGF-β	Transforming growth factor-β;
TKI	Tyrosine kinase inhibitor;
TME	Tissue microenvironment;
TNFR	Tumor necrosis factor receptor;
TRAF3	Tumor necrosis factor receptor-associated factor 3;
Trx/TrxR	Thioredoxin/thioredoxin reductase;
VCAM1	Vascular cell adhesion molecule 1;
VEGF	Vascular endothelial growth factor;
VEGFR	Vascular endothelial growth factor receptor;
Wnt	Wingless/It;
Wnt-PCP	Wnt-planar cell polarity;
xCT	xc− transporter;
X-PDT	X-ray-induced photodynamic therapy.